Characterisation of interferon α-2b by liquid chromatography and mass spectrometry techniques (CROSBI ID 167351)
Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija
Podaci o odgovornosti
Cindrić, Mario ; Vuletić, Marko
engleski
Characterisation of interferon α-2b by liquid chromatography and mass spectrometry techniques
Interferon α-2b produced by Escherichia coli consists of 165 amino acids and contains two disulphide bonds ; its purity was confirmed by LC-UV (DAD)-FLD and LC-MS techniques. A C4 column was used with UV detection at 214 nm ; diode array detector (DAD) spectra were recorded from 200-400 nm and fluorescence detection was performed at specific wavelengths of trypthophan emission and excitation. Peptide mapping was performed with trypsin. Peptides produced by trypsin digestion were analysed by LC-UV (DAD)-FLD, LC-MS, and LC-MS/MS using a C18 column. Amino acid sequence coverage was about 95%. UV spectra in the range from 200 nm to 400 nm, emission (Em) and excitation (Ex) spectra of each separated peptide were additionally compared with spectra of the same peptide produced by digestion of European Pharmacopaeia interferon α-2b standard (spectral matching). The chromatogram of any interferon α-2b (drug substance or certificated standard) sample produced in the same manner with the same amino acid composition should be similar to the chromatogram obtained by the method described in this paper. Molecular masses of peptides were obtained from MS experiments and MS/MS experiments gave additional structural information. The molecular mass of interferon α-2b was obtained by MALDI-TOF MS analysis in linear mode, with an accuracy comparable to the theoretical average mass ±5 atomic mass units. The molecular mass was obtained from the deconvoluted ESI mass spectrum.
confirmation of peptide structure ; interferon α-2b ; peak assignment ; peptide mapping ; spectral matching
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o izdanju
26 (14)
2003.
1263-1268
objavljeno
1615-9306
1615-9314
10.1002/jssc.200301419
Povezanost rada
Biologija, Farmacija, Kemija